Postprandial lipemia as a risk factor for cardiovascular disease in patients with hypothyroidism

Endocrine

Volumn 29, Issue 3, 2006, Pages 451-456

  Tanaci, Nedret ^a   Ertugrul, Derun Taner ^a   Sahin, Mustafa ^a   Yucel, Muammer ^a   Olcay, Irem ^a   Demirag, Nilgun Guvener ^a   Gursoy, Alptekin ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Cardiovascular risk; Hypothyroidism; Overt; Postprandial lipemia; Subclinical; Triglyceride

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; GLUCOSE; HOMOCYSTEINE; INSULIN; LIPOPROTEIN A; THYROTROPIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ALIMENTARY LIPEMIA; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPOTHYROIDISM; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROVOCATION TEST; RISK ASSESSMENT; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 33748479450     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:29:3:451     Document Type: Article

References (28)

1. Kreisberg, R. A. and Oberman, A. (2002). J. Clin. Endocrinol. Metab. 87, 423-437.
2. Stone, N. J., Bilek, S., and Rosenbaum, S. (2005). Am. J. Cardiol. 96, 53E-59E.
3. Hokanson, J. E. and Austin, M. A. (1996). J. Cardiovasc. Risk 3, 213-219.
4. Manninen, V., Tenkanen, L., Koskinen, P., et al. (1992). Circulation 85, 37-45.
5. Jeppesen, J., Hein, H. O., Suadicani, P., and Gyntelberg, F. (1998). Circulation 97, 1029-1036.
6. Zilversmit, D. B. (1979). Circulation 60, 473-485.
7. Cohn, J. S., McNamara, J. R., Krasinski, S. D., Russell, R. M., and Schaefer, E. J. (1989). Metabolism 38, 484-490.
8. Nicholls, S. and Lundman, P. (2004). Semin. Vasc. Med. 4, 187-195.
9. Vigna, G. B., Delli Gatti, C., and Fellin, R. (2004). Nutr. Metab. Cardiovasc. Dis. 14, 121-127.
10. Cappola, A. R. and Ladenson, P. W. (2003). J. Clin. Endocrinol. Metab. 88, 2438-2444.
11. Duntas, L. H. (2002). Thyroid 12, 287-293.
12. Martinez-Triguero, M. L., Hernandez-Mijares, A., Nguyen, T. T., et al. (1998). Mayo Clin. Proc. 73, 837-841.
13. Danese, M. D., Ladenson, P. W., Meinert, C. L., and Powe, N. R. (2000). J. Clin. Endocrinol. Metab. 85, 2993-3001.
14. Caraccio, N., Ferrannini, E., and Monzani, F. (2002). J. Clin. Endocrinol. Metab. 87, 1533-1538.
15. Palmieri, E. A., Fazio, S., Lombardi, G., and Biondi, B. (2004). Treat. Endocrinol. 3, 233-244.
16. Ladenson, P. W. (1990). Am. J. Med. 88, 638-641.
17. Steinberg, A. D. (1968). Ann. Intern. Med. 68, 338-344.
18. Nedrebo, B. G., Ericsson, U. B., Nygard, O., et al. (1998). Metabolism 47, 89-93.
19. Ozcan, O., Cakir, E., Yaman, H., et al. (2005). Clin. Endocrinol. 63, 203-206.
20. Hueston, W. J., King, D. E., and Geesey, M. E. (2005). Clin. Endocrinol. 63, 582-587.
21. Lithell, H., Boberg, J., Hellsing, K., et al. (1981). European Eur. J. Clin. Invest. 11, 3-10.
22. de Bruin, T. W., van Barlingen, H., van Linde-Sibenius, Trip, M., et al. (1993). J. Clin. Endocrinol. Metab. 76, 121-126.
23. Hokanson, J. E. and Austin, M. A. (1996). J. Cardiovasc. Risk 3, 213-219.
24. Netsel, P. J. (1964). J. Clin. Invest. 43, 943-949.
25. Cohn, J. S., McNamara, J. R., and Schaefer, E. J. (1988). Clin. Chem. 34, 2456-2459.
26. Cohn, J. S., Johnson, E. J., Millar, J. S., et al. (1993). J. Lipid. Res. 34, 2033-2040.
27. Weintraub, M., Grosskopf, I., Trostanesky, Y., Charach, G., Rubinstein, A., and Stern, N. (1999). J. Clin. Endocrinol. Metab. 84, 2532-2536.
28. Karamanos, B. G., Thanopoulou, A. C., and Roussi-Penesi, D. P. (2001). Diabet. Med. 18, 32-39.